Two new cancer-focused findings highlight distinct mechanisms that could expand therapeutic entry points. First, researchers reported that novel molecular drivers shape the invasive margins of oral squamous cell carcinoma (OSCC), with the work published in Cell Death Discovery and framed as a redefinition of how tumor invasion fronts are organized at the molecular level. Second, investigators described RBM41 as a driver of colorectal cancer progression by blocking NDRG1 maturation, identifying an RNA-binding motif protein–linked pathway that supports tumor growth. The report frames RBM41 as a facilitator of tumorigenesis through post-transcriptional control of maturation processes. For drug developers, both studies point to more granular, mechanism-based targets—one focused on invasion dynamics in OSCC and the other on maturation regulation in colorectal cancer—potentially informing next-generation target validation and biomarker strategies.